What is the ticker symbol for Akero Therapeutics?

Akero Therapeutics trades under the ticker AKRO on NASDAQ.

What sector does Akero Therapeutics operate in?

Akero Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze AKRO in a portfolio?

PortView shows AKRO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Akero Therapeutics (AKRO) Stock Analysis

NASDAQHealthcareBiotechnology

$54.65+0.00%

1-year price historyRange $21.87 – $57.56

52-week range$54.65

$21.34$58.40

What Akero Therapeutics does

Akero Therapeutics, Inc. is a biopharmaceutical firm dedicated to addressing cardio-metabolic disorders, with a specific focus on nonalcoholic steatohepatitis (NASH). Its primary objective is the creation of therapeutic agents aimed at re-establishing metabolic equilibrium and enhancing overall well-being. The company's flagship investigational drug is efruxifermin (EFX), a synthetic analog of fibroblast growth factor 21. EFX is designed to shield cells from stress and modulate the systemic metabolism of fats, carbohydrates, and proteins throughout the body. This promising compound is currently undergoing evaluation in a Phase 2a clinical investigation, known as the BALANCED study, for individuals diagnosed with biopsy-confirmed NASH. Originally established as Pippin Pharmaceuticals, Inc., the organization rebranded as Akero Therapeutics, Inc. in May 2018. Founded in 2017, Akero Therapeutics maintains its corporate headquarters in South San Francisco, California.

Key metrics

Market cap

$4.50B

P/E (TTM)

-14.57

EPS (TTM)

$-3.75

Beta

-0.40

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$53.06

200-day avg

$48.19

52-week high

$58.40

52-week low

$21.34

CEO

Andrew Cheng

ETFs linked to AKRO

Broad-market and Healthcare sector ETFs an investor holding Akero Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how AKRO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze AKRO in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Akero Therapeutics?: Akero Therapeutics trades under the ticker AKRO on NASDAQ.
Which exchange is AKRO listed on?: AKRO is listed on NASDAQ.
What sector does Akero Therapeutics operate in?: Akero Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze AKRO in a portfolio?: PortView shows AKRO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.